A  	A  	 DT	O
proliferation-inducing  	proliferation-inducing  	 JJ	B-NP
ligand  	ligand  	 NN	I-NP
in  	in  	 IN	O
atopic  	atopic  	 JJ	B-NP
dermatitis  	dermatitis  	 NN	I-NP
and  	and  	 CC	O
vitiligo  	vitiligo  	 VBG	O
A  	A  	 DT	B-NP
proliferation-inducing  	proliferation-inducing  	 JJ	I-NP
ligand  	ligand  	 NNS	I-NP
( 	( 	 -LRB-	O
APRIL 	APRIL 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
tumor  	tumor  	 NN	B-NP
necrosis  	necrosis  	 NN	I-NP
factor  	factor  	 NN	I-NP
( 	( 	 -LRB-	O
TNF 	TNF 	 NNP	B-NP
)  	)  	 -RRB-	O
superfamily  	superfamily  	 JJ	B-NP
member  	member  	 NN	I-NP
ligand  	ligand  	 NN	I-NP
that  	that  	 IN	O
stimulates  	stimulates  	 JJ	O
B cells  	B cells  	 NN	B-NP
in  	in  	 IN	O
vitro  	vitro  	 NN	B-NP
and  	and  	 CC	O
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
.  	.  	 .	O
It  	It  	 PRP	O
also  	also  	 RB	O
plays  	plays  	 VBZ	O
an  	an  	 DT	O
important  	important  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
T cell  	T cell  	 CD	B-NP
activation  	activation  	 NNS	I-NP
and  	and  	 CC	O
survival 	survival 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
conducted  	conducted  	 VBN	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
serum  	serum  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	O
APRIL  	APRIL  	 NNP	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
atopic  	atopic  	 JJ	B-NP
dermatitis  	dermatitis  	 NNS	I-NP
( 	( 	 -LRB-	O
AD 	AD 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
vitiligo  	vitiligo  	 NNS	B-NP
and  	and  	 CC	O
their  	their  	 PRP$	O
correlation  	correlation  	 NN	O
with  	with  	 IN	O
disease  	disease  	 NN	B-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
100  	100  	 CD	O
subjects  	subjects  	 NNS	B-NP
were  	were  	 VBD	O
included 	included 	 VBN	O
;  	;  	 :	O
these  	these  	 DT	O
comprised  	comprised  	 JJ	O
40  	40  	 CD	O
AD  	AD  	 NN	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
40  	40  	 CD	O
vitiligo  	vitiligo  	 CD	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
20  	20  	 CD	O
control  	control  	 NN	B-NP
subjects 	subjects 	 NNS	I-NP
.  	.  	 .	O
Serum  	Serum  	 NNP	B-NP
APRIL  	APRIL  	 NNP	O
levels  	levels  	 NNS	O
were  	were  	 VBD	O
measured  	measured  	 VBN	O
and  	and  	 CC	O
their  	their  	 PRP$	O
relationships  	relationships  	 NNS	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
severity  	severity  	 NN	O
of  	of  	 IN	O
AD  	AD  	 NNP	O
and  	and  	 CC	O
activity  	activity  	 NN	O
of  	of  	 IN	O
vitiligo  	vitiligo  	 JJ	O
evaluated  	evaluated  	 NNS	O
according  	according  	 VBG	O
to  	to  	 TO	O
scores  	scores  	 NNS	O
on  	on  	 IN	O
the  	the  	 DT	O
SCORAD  	SCORAD  	 NNP	B-NP
( 	( 	 -LRB-	O
SCORing  	SCORing  	 JJ	B-NP
of  	of  	 IN	I-NP
Atopic  	Atopic  	 NNP	I-NP
Dermatitis 	Dermatitis 	 NNP	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
VIDA  	VIDA  	 NNP	B-NP
( 	( 	 -LRB-	O
Vitiligo  	Vitiligo  	 NNP	B-NP
Disease  	Disease  	 NNP	I-NP
Activity 	Activity 	 NNP	I-NP
)  	)  	 -RRB-	O
indices 	indices 	 NNS	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
serum  	serum  	 JJ	B-NP
level  	level  	 NN	I-NP
of  	of  	 IN	O
APRIL  	APRIL  	 NNP	O
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
AD  	AD  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
than  	than  	 IN	O
in  	in  	 IN	O
the  	the  	 DT	O
control  	control  	 NN	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
Serum  	Serum  	 NNP	B-NP
APRIL  	APRIL  	 NNP	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
severe  	severe  	 JJ	O
AD  	AD  	 NNP	O
showed  	showed  	 VBD	O
a  	a  	 DT	O
statistically  	statistically  	 JJ	O
significant  	significant  	 JJ	O
difference  	difference  	 NN	O
with  	with  	 IN	O
serum  	serum  	 JJ	B-NP
APRIL  	APRIL  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
either  	either  	 DT	O
mild  	mild  	 JJ	O
or  	or  	 CC	O
moderate  	moderate  	 JJ	O
AD 	AD 	 NNP	O
.  	.  	 .	O
Serum  	Serum  	 NNP	B-NP
APRIL  	APRIL  	 NNP	O
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
vitiligo  	vitiligo  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
than  	than  	 IN	O
in  	in  	 IN	O
the  	the  	 DT	O
control  	control  	 NN	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
Differences  	Differences  	 NNS	O
in  	in  	 IN	O
serum  	serum  	 JJ	B-NP
APRIL  	APRIL  	 NN	O
among  	among  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
different  	different  	 JJ	O
VIDA  	VIDA  	 NN	B-NP
scores  	scores  	 NNS	I-NP
were  	were  	 VBD	O
significant  	significant  	 JJ	O
only  	only  	 JJ	O
between  	between  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
VIDA  	VIDA  	 NNP	B-NP
scores  	scores  	 NNS	I-NP
of  	of  	 IN	O
+1  	+1  	 NNP	O
and  	and  	 CC	O
+4 	+4 	 NNP	O
.  	.  	 .	O
Statistically  	Statistically  	 RB	O
significant  	significant  	 JJ	O
positive  	positive  	 JJ	B-NP
correlations  	correlations  	 NN	I-NP
emerged  	emerged  	 VBD	O
between  	between  	 IN	O
serum  	serum  	 JJ	B-NP
APRIL  	APRIL  	 NNP	O
and  	and  	 CC	O
activity  	activity  	 NN	O
of  	of  	 IN	O
AD  	AD  	 NNP	O
( 	( 	 -LRB-	O
r = 0.939 	r = 0.939 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
vitiligo  	vitiligo  	 NNS	B-NP
( 	( 	 -LRB-	O
r = 0.740 	r = 0.740 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
APRIL  	APRIL  	 NNP	O
may  	may  	 MD	O
play  	play  	 VB	O
a  	a  	 DT	O
role  	role  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
pathogeneses  	pathogeneses  	 NN	B-NP
of  	of  	 IN	O
AD  	AD  	 NNP	O
and  	and  	 CC	O
vitiligo  	vitiligo  	 NNS	B-NP
and  	and  	 CC	O
could  	could  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
as  	as  	 IN	O
an  	an  	 DT	O
objective  	objective  	 JJ	B-NP
marker  	marker  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
assessment  	assessment  	 NN	O
of  	of  	 IN	O
AD  	AD  	 NNP	B-NP
severity  	severity  	 NN	I-NP
and  	and  	 CC	O
vitiligo  	vitiligo  	 JJ	B-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
are  	are  	 VBP	O
required  	required  	 VBN	O
to  	to  	 TO	O
clarify  	clarify  	 VB	O
the  	the  	 DT	O
precise  	precise  	 JJ	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
APRIL  	APRIL  	 NNP	O
in  	in  	 IN	O
the  	the  	 DT	O
pathogeneses  	pathogeneses  	 NN	B-NP
of  	of  	 IN	O
AD  	AD  	 NNP	O
and  	and  	 CC	O
vitiligo  	vitiligo  	 NNS	B-NP
and  	and  	 CC	O
to  	to  	 TO	O
test  	test  	 VB	O
the  	the  	 DT	O
possible  	possible  	 JJ	O
use  	use  	 NN	O
of  	of  	 IN	O
APRIL  	APRIL  	 NNP	O
inhibitors  	inhibitors  	 NN	O
as  	as  	 IN	O
novel  	novel  	 NN	O
modalities  	modalities  	 NN	O
of  	of  	 IN	O
therapy 	therapy 	 NN	O
.  	.  	 .	O
